Impact of age on hospital outcomes after catheter ablation for ventricular tachycardia

被引:1
|
作者
Tan, Min Choon [1 ,2 ]
Yeo, Yong Hao [3 ]
Ang, Qi Xuan [4 ,5 ]
Kiwan, Chrystina [2 ]
Fatunde, Olubadewa [1 ]
Lee, Justin Z. [6 ]
Tolat, Aneesh [7 ]
Sorajja, Dan [1 ,8 ]
机构
[1] Mayo Clin, Dept Cardiovasc Med, Phoenix, AZ USA
[2] St Michaels Hosp, New York Med Coll, Dept Internal Med, Newark, NJ USA
[3] William Beaumont Univ Hosp, Dept Internal Med Pediat, Royal Oak, MI USA
[4] Sparrow Hlth Syst, Dept Internal Med, E Lansing, MI USA
[5] Michigan State Univ, E Lansing, MI USA
[6] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH USA
[7] Univ Connecticut, Hartford Healthcare, Dept Cardiovasc Med, Hartford, CT USA
[8] Mayo Clin Arizona, Dept Cardiovasc Med, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA
关键词
adult; catheter ablation; elderly; hospital outcome; ventricular tachycardia; CARDIOVASCULAR-DISEASE ENTERPRISES; ELDERLY-PATIENTS; MAJOR SHAREHOLDERS; HEART; MORTALITY; COMPLICATIONS; PREDICTORS; ARTERIAL; EFFICACY; SAFETY;
D O I
10.1002/joa3.12998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The real-world data on the safety profile of ventricular tachycardia (VT) ablation among elderly patients is not well-established. This study aimed to evaluate the procedural outcomes among those aged 18-64 years versus those aged >= 65 years who underwent catheter ablation of VT. Method Using the Nationwide Readmissions Database, our study included patients aged >= 18 years who underwent VT catheter ablation between 2017 and 2020. We divided the patients into non-elderly (18-64 years old) and elderly age groups (>= 65 years old). We then analyzed the in-hospital procedural outcome and 30-day readmission between these two groups. Results Our study included 2075 (49.1%) non-elderly patients and 2153 (50.9%) elderly patients who underwent VT ablation. Post-procedurally, elderly patients had significantly higher rates of prolonged index hospitalization (>= 7 days; 35.5% vs. 29.3%, p < .01), non-home discharge (13.4% vs. 6.0%, p < .01), 30-day readmission (17.0% vs. 11.4%, p < .01), and early mortality (5.5% vs. 2.4%, p < .01). There was no significant difference in the procedural complications between two groups, namely vascular complications, hemopericardium/cardiac tamponade, cerebrovascular accident (CVA), major bleeding requiring blood transfusion, and systemic embolization. Through multivariable analysis, the elderly group was associated with higher odds of early mortality (OR: 7.50; CI 1.86-30.31, p = .01), non-home discharge (OR: 2.41; CI: 1.93-3.00, p < .01) and 30-day readmission (OR: 1.58; CI 1.32-1.89, p < .01). Conclusion Elderly patients have worse in-hospital outcome, early mortality, non-home discharge, and 30-day readmission following catheter ablation for VT. There was no significant difference between elderly and non-elderly groups in the procedural complications.
引用
收藏
页码:317 / 324
页数:8
相关论文
共 50 条
  • [21] In-hospital outcomes of ventricular tachycardia catheter ablation in the presence of intra-cardiac thrombus
    Margolis, G.
    Aviad, C.
    Barel, M.
    Kazatsker, M.
    Kobo, O.
    Roguin, A.
    Leshem, E.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [22] In-hospital outcomes of ventricular tachycardia catheter ablation in the presence of intra-cardiac thrombus
    Margolis, G.
    Aviad, C.
    Barel, M.
    Kazatsker, M.
    Kobo, O.
    Roguin, A.
    Leshem, E.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [23] Catheter ablation compared to medical therapy for ventricular tachycardia in sarcoidosis: nationwide outcomes and hospital readmissions
    Gurin, Michael I.
    Xia, Yuhe
    Tarabanis, Constantine
    Goldberg, Randal I.
    Knotts, Robert J.
    Donnino, Robert
    Reyentovich, Alex
    Bernstein, Scott
    Jankelson, Lior
    Kushnir, Alexander
    Holmes, Douglas
    Spinelli, Michael
    Park, David S.
    Barbhaiya, Chirag R.
    Chinitz, Larry A.
    Aizer, Anthony
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2024, 44
  • [24] TRENDS AND OUTCOMES IN CATHETER ABLATION OF VENTRICULAR TACHYCARDIA IN ISCHEMIC CARDIOMYOPATHY
    Harikrishnan, P.
    Kolte, D.
    Palaniswamy, C.
    Khera, S.
    Mujib, M.
    Aronow, W. S.
    Iwai, S.
    Eugenio, P.
    Lessner, S.
    Ferrick, A.
    Ahmed, A.
    Fonarow, G. C.
    Frishman, W. H.
    Panza, J. A.
    CARDIOLOGY, 2014, 128 : 181 - 181
  • [25] Trends and Outcomes of Catheter Ablation for Ventricular Tachycardia in a Community Cohort
    Yousuf, Omair K.
    Zusterzeel, Robbert
    Sanders, William
    Canos, Daniel
    Dekmezian, Carmen
    Silverman, Henry
    Calkins, Hugh
    Berger, Ronald
    Tandri, Harikrishna
    Nazarian, Saman
    Strauss, David G.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2018, 4 (09) : 1189 - 1199
  • [26] Outcomes of catheter ablation in cardiac sarcoidosis patients with ventricular tachycardia
    Altaii, Haider
    Saxena, Ritika
    Gaalema, Diann
    Narayanan, Chockalingam
    Morcos, Ramez
    Sabayon, Muhie Dean
    Jneid, Hani
    CIRCULATION, 2024, 150
  • [27] Ventricular Tachycardia in Cardiac Sarcoidosis Characterization of Ventricular Substrate and Outcomes of Catheter Ablation
    Kumar, Saurabh
    Barbhaiya, Chirag
    Nagashima, Koichi
    Choi, Eue-Keun
    Epstein, Laurence M.
    John, Roy M.
    Maytin, Melanie
    Albert, Christine M.
    Miller, Amy L.
    Koplan, Bruce A.
    Michaud, Gregory F.
    Tedrow, Usha B.
    Stevenson, William G.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2015, 8 (01): : 87 - U136
  • [28] Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
    Philips, Binu
    Madhavan, Srinivasa
    James, Cynthia
    Tichnell, Crystal
    Murray, Brittney
    Dalal, Darshan
    Bhonsale, Aditya
    Nazarian, Saman
    Judge, Daniel P.
    Russell, Stuart D.
    Abraham, Theodore
    Calkins, Hugh
    Tandri, Harikrishna
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (03): : 499 - 505
  • [29] Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy
    Huang, J.
    Fang, X. H.
    Zhan, X. Z.
    Xue, Y. M.
    Zhang, Q. H.
    Chen, C. H.
    Liu, T.
    Wu, S. L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S237 - S237
  • [30] Impact of the inflammation on the outcomes of catheter ablation of drug-refractory ventricular tachycardia in cardiac sarcoidosis
    Kaur, Daljeet
    Roukoz, Henri
    Shah, Mandar
    Yalagudri, Sachin
    Pandurangi, Ulhas
    Chennapragada, Sridevi
    Narasimhan, Calambur
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (03) : 612 - 620